Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

2,858 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
High-dose 7-hexanoyltaxol-eluting stent with polymer sleeves for coronary revascularization: one-year results from the SCORE randomized trial.
Grube E, Lansky A, Hauptmann KE, Di Mario C, Di Sciascio G, Colombo A, Silber S, Stumpf J, Reifart N, Fajadet J, Marzocchi A, Schofer J, Dumas P, Hoffmann R, Guagliumi G, Pitney M, Russell ME; SCORE randomized trial. Grube E, et al. Among authors: hoffmann r. J Am Coll Cardiol. 2004 Oct 6;44(7):1368-72. doi: 10.1016/j.jacc.2004.06.054. J Am Coll Cardiol. 2004. PMID: 15464315 Free article. Clinical Trial.
A double-blind, randomized, placebo-controlled multicenter clinical trial to evaluate the effects of the angiotensin II receptor blocker candesartan cilexetil on intimal hyperplasia after coronary stent implantation.
Radke PW, Figulla HR, Drexler H, Klues HG, Mügge A, Silber S, Daniel W, Schmeisser A, Reifart N, Motz W, Büttner HJ, Fischer D, Ortlepp JR, Schaefers K, Hoffmann R, Hanrath P; AACHEN Trial Investigators. Radke PW, et al. Among authors: hoffmann r. Am Heart J. 2006 Oct;152(4):761.e1-6. doi: 10.1016/j.ahj.2006.07.003. Am Heart J. 2006. PMID: 16996855 Clinical Trial.
Vascular response to sirolimus-eluting stents delivered with a nonaggressive implantation technique: comparison of intravascular ultrasound results from the multicenter, randomized E-SIRIUS, and SIRIUS trials.
Hoffmann R, Guagliumi G, Musumeci G, Reimers B, Petronio AS, Disco C, Amoroso G, Moses JW, Fitzgerald PJ, Schofer J, Leon MB, Breithardt G. Hoffmann R, et al. Catheter Cardiovasc Interv. 2005 Dec;66(4):499-506. doi: 10.1002/ccd.20542. Catheter Cardiovasc Interv. 2005. PMID: 16273564 Clinical Trial.
Evaluation of a high-dose dexamethasone-eluting stent.
Hoffmann R, Langenberg R, Radke P, Franke A, Blindt R, Ortlepp J, Popma JJ, Weber C, Hanrath P. Hoffmann R, et al. Am J Cardiol. 2004 Jul 15;94(2):193-5. doi: 10.1016/j.amjcard.2004.03.061. Am J Cardiol. 2004. PMID: 15246899
Six-month results of the NEVO Res-Elution I (NEVO RES-I) trial: a randomized, multicenter comparison of the NEVO sirolimus-eluting coronary stent with the TAXUS Liberté paclitaxel-eluting stent in de novo native coronary artery lesions.
Ormiston JA, Abizaid A, Spertus J, Fajadet J, Mauri L, Schofer J, Verheye S, Dens J, Thuesen L, Dubois C, Hoffmann R, Wijns W, Fitzgerald PJ, Popma JJ, Macours N, Cebrian A, Stoll HP, Rogers C, Spaulding C; NEVO ResElution-I Investigators. Ormiston JA, et al. Among authors: hoffmann r. Circ Cardiovasc Interv. 2010 Dec;3(6):556-64. doi: 10.1161/CIRCINTERVENTIONS.110.946426. Epub 2010 Nov 9. Circ Cardiovasc Interv. 2010. PMID: 21062998 Clinical Trial.
2,858 results